37 results
Cardiovascular and renal effects comparison between SGLT-2 inhibitors
 - Canagliflozin (Invokana)
 - Dapagliflozin (Farxiga)
 - Empagliflozin
Cardiovascular and renal ... between SGLT-2 inhibitors ... (Steglatro) #diabetes ... #SGLT2i #Inhibitors ... #pharmacology
SGLT2 Inhibitors 
SGLT2 inhibitors are the newest class of anti-diabetic medications, with the first one (Canagliflozin)
class of anti-diabetic ... in the nephron (kidney ... need to have good kidney ... #Pharmacology # ... #Endocrinology
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
DPP4 Inhibitors ... double check the kidney ... #Pharmacology #Management ... #Diabetes #DM2 ... #Endocrinology
Comparison of anti-diabetic or anti-hyperglycemic agents

There are numerous anti-hyperglycemic agents available to manage Type 2 diabetes.
Comparison of anti-diabetic ... manage Type 2 diabetes ... #pharmacology #pharmacotherapy ... #endocrinology ... #treatment
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
• Nephrogenic diabetes ... Lithium-induced nephrogenic diabetes ... DDAVP) • Central diabetes ... Tolvaptan) • Treatment ... Diuresis #Nephrology #Pharmacology
SGLT2 Inhibitors - Pharmacology Summary
Mechanisms of Action: Inhibits SGLT2 (sodium/glucose cotransporter 2) in the proximal tubule,
- Pharmacology ... • Euglycemic diabetic ... #Pharmacology # ... Summary #DM2 #diabetes ... #endocrinology
Metformin Treatment in Patients With Type 2 Diabetes and Chronic Kidney Disease Stages 3A, 3B, or
Metformin Treatment ... Patients With Type 2 Diabetes ... and Chronic Kidney ... 3A, 3B, or 4 Diabetes ... #CKD4 #Dosing #Pharmacology
Patient factors influencing the selection Of glucose-lowering drugs Other than SGLT2i and metformin in T2D and
alpha-glucosidase inhibitor ... CKD. chronic kidney ... cotransporter-2 inhibitor ... type 2 diabetes; ... CKD #management #treatment
Anastrozole is a Selective non-steroidal aromatase Inhibitor. Used for the treatment of breast cancer in postmenopausal
non-steroidal aromatase Inhibitor ... Used for the treatment ... which converts adrenal ... #pharmacology #overview ... #endocrinology
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Sulfonylurea, TZD, DPP-4 inhibitor ... α-glucosidase inhibitor ... insulin dose for renal ... #Medications #pharmacology ... comparison #table #endocrinology